New insights into the mechanisms of anandamide-induced airway dilation placing its degradation enzyme, FAAH center stage. Commentary on: Simon A, von Einem T, Seidinger A, Matthey M, Bindila L, Wenzel D (2022) The endocannabinoid anandamide is an airway relaxant in health and disease. Nat Commun 13:6941
Open Access
- 1 March 2023
- journal article
- editorial
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 475 (5) , 557-559
Abstract
No abstract availableFunding Information
- Universitätsklinikum Köln
This publication has 12 references indexed in Scilit:
- Untapped Potential: Therapeutically Targeting Eicosanoids and Endocannabinoids in the LungClinical Pharmacology & Therapeutics, 2021
- Molecular Mechanism and Cannabinoid Pharmacology2019
- The endogenous cannabinoid anandamide increases human airway epithelial cell permeability through an arachidonic acid metabolitePharmacological Research, 2016
- The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pigPulmonary Pharmacology & Therapeutics, 2013
- Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic AsthmaClinical Pharmacology & Therapeutics, 2011
- Lipid metabolites as regulators of airway smooth muscle functionPulmonary Pharmacology & Therapeutics, 2009
- Inhaled anandamide reduces leukotriene D4-induced airway obstruction in guinea pigsEuropean Journal of Pharmacology, 2007
- Endogenous Cannabinoid Receptor Agonists Inhibit Neurogenic Inflammations in Guinea Pig AirwaysInternational Archives of Allergy and Immunology, 2005
- Bidirectional control of airway responsiveness by endogenous cannabinoidsNature, 2000
- Characterization of the effects of cannabinoids on guinea‐pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nervesBritish Journal of Pharmacology, 2000